Study 7 of 8 for search of: "Gangliosidoses"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Diagnostic and Screening Study of Genetic Disorders
This study has been completed.
Sponsors and Collaborators: National Center for Research Resources (NCRR)
Mount Sinai School of Medicine
Information provided by: National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier: NCT00006057
  Purpose

OBJECTIVES: I. Determine the phenotypic heterogeneity of patients with genetic disorders including their clinical spectrum and natural history.

II. Develop and evaluate novel methods for the treatment of genetic disorders including metabolic manipulation, enzyme manipulation, enzyme replacement, enzyme transplantation, and gene transfer techniques in these patients.

III. Develop and evaluate methods for the prenatal diagnosis of genetic disorders using improved cytogenetic, biochemical, and nucleic acid techniques and amniotic fluid cells or chorionic villi in these patients.


Condition
Tay-Sachs Disease
Porphyria, Erythropoietic
Leukodystrophy, Globoid Cell
Metabolism, Inborn Errors

Genetics Home Reference related topics: cholesteryl ester storage disease Farber lipogranulomatosis GM2-gangliosidosis, AB variant Krabbe disease leukoencephalopathy with vanishing white matter long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency megalencephalic leukoencephalopathy with subcortical cysts mitochondrial trifunctional protein deficiency porphyria primary carnitine deficiency Sandhoff disease Tay-Sachs disease
MedlinePlus related topics: Leukodystrophies Porphyria Tay-Sachs Disease
U.S. FDA Resources
Study Type: Observational
Study Design: Screening

Further study details as provided by National Center for Research Resources (NCRR):

Estimated Enrollment: 50
Study Start Date: December 1999
Detailed Description:

PROTOCOL OUTLINE:

Patients are evaluated annually or biannually, depending on disease status and progression. Patients undergo a complete medical history, an extensive family pedigree, and a physical examination. Patients undergo general laboratory, imaging, physiologic, and clinical laboratory studies according to their disease type. Patients undergo specialized laboratory studies including plasma and leukocyte enzyme assays, quantitative urinary mucopolysaccharides and oligosaccharides, urine and plasma glycolipids, plasma and urine amino acids, urine organic acids, lymphoblastoid culture, DNA isolation from peripheral leukocytes, skin biopsy for fibroblast culture (if indicated), and medical photography. Patients also receive consultations with various specialties including ophthalmology, ENT, cardiology, pulmonary, gastroenterology/nutrition, hematology, neurology, orthopedics, rehabilitation medicine/physical therapy, and dermatology.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • Suspected diagnosis (homozygous or heterozygous) of a genetic disorder including, but not limited to, one of the following: Tay-Sachs disease (adult form) Congenital erythropoietic porphyria Galactosemia Mitochondrial myopathy Globoid cell leukodystrophy (Krabbe disease) Methylmalonic acidemia Isovaleric acidemia Morquio type A Glycogen storage disease type 1AB Ornithine aminotransferase deficiency Ceroid lipofuscinosis Glutaric aciduria type 1 Citrullinemia Other malformation syndromes, lysosomal storage disorders, or peroxisomal disorders
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00006057

Locations
United States, New York
Mount Sinai School of Medicine
New York, New York, United States, 10029
Sponsors and Collaborators
Mount Sinai School of Medicine
Investigators
Study Chair: Judith P. Willner Mount Sinai School of Medicine
  More Information

Study ID Numbers: 199/15151, MTS-GCO-88-459
Study First Received: July 5, 2000
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00006057  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Lipid Metabolism, Inborn Errors
Gangliosidosis (GM2) Type1
Sphingolipidoses
Porphyrias
Demyelinating diseases
Porphyria, congenital erythropoietic
Tay-Sachs disease
Brain Diseases
Leukodystrophy
Krabbe leukodystrophy
Metabolism, Inborn Errors
Brain Diseases, Metabolic, Inborn
Porphyria, Erythropoietic
Tay-Sachs Disease
Skin Diseases, Genetic
Leukodystrophy, Globoid Cell
Metabolic Diseases
Demyelinating Diseases
Skin Diseases
Lysosomal Storage Diseases
Sphingolipidosis
Central Nervous System Diseases
Genetic Diseases, Inborn
Gangliosidoses, GM2
Lipidoses
Metabolic disorder
Gangliosidoses
Brain Diseases, Metabolic
Lipid Metabolism Disorders

Additional relevant MeSH terms:
Skin Diseases, Metabolic
Lysosomal Storage Diseases, Nervous System
Nervous System Diseases
Hereditary Central Nervous System Demyelinating Diseases

ClinicalTrials.gov processed this record on January 16, 2009